BACKGROUND AND AIMS: Analysis of mortality from the national health registries and data from a specific central registry dealing with the implantation of pacemakers (REPACE) in Czech patients. METHODS AND RESULTS: Retrospective observational analysis of pacemakers' implantation in all Czech patients [n = 82,791; 47,070 (56.9%) men, 75.9 ± 10.4 years old] between 2010 and 2021. Almost 114,000 pacemakers were implanted between 2010 and 2021, of which 27.9% were single-chamber, 67.4% were dual-chamber and 4.6% were biventricular. The annual number of implantations has been steadily increasing with a 6% annual decline in 2020 with increased mortality and reductions in care provided, likely related to COVID-19. The observed 5-year relative survival was 88.6% (overall survival 60.6%) and the 10-year relative survival was 75.9% (overall survival 32.7%). Causes of death 5ary according to the age of the patient. The highest difference 1n the reported numbers in the REPACE Registry did not exceed 2% in comparison with the National Register of Reimbursed Health Services. CONCLUSION: This study followed all Czech patients with pacemaker's implantation in between 2010 and 2021. The annual number of 1mplantations has been steadily 1ncreasing. Patients with implanted pacemakers had a significantly higher mortality than the average population. Number of patients in the registry corresponded almost perfectly with the National Register of Reimbursed Health Services.

Cardiac Centre Institute for Clinical and Experimental Medicine IKEM Praha Czech Republic

Department of Internal Medicine 1 Cardiology University Hospital Olomouc Olomouc Czech Republic

Faculty of Medicine Institute of Biostatistics and Analyses Masaryk University Kamenice Czech Republic

Institute of Health Information and Statistics of the Czech Republic Praha Czech Republic

Zobrazit více v PubMed

Nielsen JC. National registry data on implantable cardioverter defibrillator treatment: what are they useful for? Europace. (2009) 11(4):405–6. 10.1093/europace/eup007 PubMed DOI

Niederlander CS, Kriza C, Kolominsky-Rabas P. Quality criteria for medical device registries: best practice approaches for improving patient safety—a systematic review of international experiences. Expert Rev Med Devices. (2017) 14(1):49–64. 10.1080/17434440.2017.1268911 PubMed DOI

Torre M, Romanini E, Zanoli G, Carrani E, Luzi I, Leone L, et al. Monitoring outcome of joint arthroplasty in Italy: implementation of the national registry. Joints. (2017) 5(2):70–8. 10.1055/s-0037-1603899 PubMed DOI PMC

Valzania C, Torbica A, Tarricone R, Leyva F, Boriani G. Implant rates of cardiac implantable electrical devices in Europe: a systematic literature review. Health Policy. (2016) 120(1):1–15. 10.1016/j.healthpol.2015.11.001 PubMed DOI

van Steenbergen LN, Denissen GA, Spooren A, van Rooden SM, van Oosterhout FJ, Morrenhof JW, et al. More than 95% completeness of reported procedures in the population-based Dutch arthroplasty register. Acta Orthop. (2015) 86(4):498–505. 10.3109/17453674.2015.1028307 PubMed DOI PMC

Lazarus A, Biondi N, Thebaut JF, Durand-Zaleski I, Chauvin M. Implantable cardioverter–defibrillators in France: practices and regional variability. Europace. (2011) 13:1568–73. 10.1093/europace/eur238 PubMed DOI

Global number of pacemakers in 2016 and a forecast for 2023 (in million units). Available at: (URL).

Zecchin M, Torre M, Carrani E, Sampaolo L, Ciminello E, Ortis B, et al. Seventeen-year trend (2001–2017) in pacemaker and implantable cardioverter-defibrillator utilization based on hospital discharge database data: an analysis by age groups. Eur J Intern Med. (2021) 84:38–45. 10.1016/j.ejim.2020.09.003 PubMed DOI

Bannehr M, Reiners D, Lichtenauer M, Kopp K, Jirak P, Georgi C, et al. Impact of socioeconomic aspects on cardiac implantable electronic device treatment and application of the EHRA guidelines: a European comparison. Wien Klin Wochenschr. (2022) 134(17-18):646–53. 10.1007/s00508-022-02056-5 PubMed DOI

Boriani G, Proietti M, Bertini M, Diemberger I, Palmisano P, Baccarini S, et al. Incidence and predictors of infections and all-cause death in patients with cardiac implantable electronic devices: the Italian nationwide RI-AIAC registry. J Pers Med. (2022) 12(1):91. 10.3390/jpm12010091 PubMed DOI PMC

Sichrovsky T, Mittal S. I need a pacemaker-what are my options? JAMA Cardiol. (2020) 5:1456. 10.1001/jamacardio.2020.5665 PubMed DOI

Raatikainen MP, Arnar DO, Merkely B, Nielsen JC, Hindricks G, Heidbuchel H, et al. A decade of information on the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European society of cardiology countries: 2017 report from the European heart rhythm association. Europace. (2017) 19(Suppl_2):ii1–ii90. 10.1093/europace/eux258 PubMed DOI

Proclemer A, Zecchin M, D'Onofrio A, Boriani G. The pacemaker and implantable cardioverter-defibrillator registry of the Italian association of arrhythmology and cardiac pacing—annual report 2017. G Ital Cardiol. (2019) 20(3):136–48. 10.1714/3108.30963 PubMed DOI

Kipp R, Hsu JC, Freeman J, Curtis J, Bao H, Hoffmayer KS. Long-term morbidity and mortality after implantable cardioverter-defibrillator implantation with procedural complication: a report from the national cardiovascular data registry. Heart Rhythm. (2018) 15(6):847–54. 10.1016/j.hrthm.2017.09.043 PubMed DOI

Brunner M, Olschewski M, Geibel A, Bode C, Zehender M. Long-term survival after pacemaker implantation: prognostic importance of gender and baseline patient characteristics.. Eur Heart J. (2004) 25(1):88–95. 10.1016/j.ehj.2003.10.022 PubMed DOI

Jastrzębski M, Kiełbasa G, Cano O, Curila K, Heckman L, De Pooter J, et al. Left bundle branch area pacing outcomes: the multicentre European MELOS study. Eur Heart J. (2022) 43(40):4161–73. 10.1093/eurheartj/ehac445 PubMed DOI PMC

Burri H, Jastrzebski M, Cano Ó, Čurila K, de Pooter J, Huang W, et al. EHRA clinical consensus statement on conduction system pacing implantation: endorsed by the Asia Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS), and Latin American Heart Rhythm Society (LAHRS). Europace. (2023) 25(4):1208–36. 10.1093/europace/euad043 PubMed DOI PMC